Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    general medicine

    Tumour lysis syndrome

    Also known as: TLS, Acute tumour lysis syndrome, ATLS, Tumor lysis syndrome

    Tumour lysis syndrome (TLS) is a potentially fatal oncological emergency resulting from rapid tumour-cell breakdown, which releases intracellular contents and produces electrolyte disturbances, hyperuricaemia, and acute kidney injury. It can follow anticancer treatment or occur spontaneously, posing a risk of cardiac arrhythmias or seizures. Suspected cases necessitate immediate hospital assessment and oncology-led inpatient management; TLS is not amenable to primary TCM intervention. Acupuncture and Chinese herbal medicine have no therapeutic role in acute TLS. Adjunctive symptom management may only be considered following complete medical stabilisation and formal oncology clearance. Cited evidence includes one fatal case of small-cell lung cancer and three pharmacovigilance reports; none evaluates acupuncture or Chinese herbal treatment for this condition. Recovery-phase patterns are traditional descriptive frameworks and are not validated TLS treatments.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Ensure strict adherence to all scheduled oncology consultations and pathology monitoring, irrespective of perceived wellness.
    • •Adhere to the precise fluid, dietary, and electrolyte requirements prescribed by the medical team; refrain from unsupervised use of electrolyte solutions or supplements.
    • •Maintain a comprehensive current list of all pharmacological and supplemental agents; keep oncology emergency contact details readily available at all times.
    • •Reintroduce physical activity progressively following medical clearance; report any alterations in urine output, appetite, weight, or exercise tolerance to the medical team.

    Cautions & Contraindications

    See sources
    • •Suspected or active TLS excludes acupuncture and herbal treatment: stop the consultation and arrange emergency care. Source 4 supports urgency but does not evaluate complementary-treatment contraindications.[]
    • •Do not prescribe forced oral hydration or urine alkalinisation in the clinic. Their use in the single case in source 4 is not evidence of general safety or benefit; fluid and acid–base management belong to the hospital team.[]
    • •Defer needling in patients with fever, suspected infection, clinically significant neutropenia or bleeding risk until the oncology team has assessed safety. Source 2 reports neutropenia and infection signals, not acupuncture-specific thresholds.[]
    • •Withhold Chinese herbs while kidney function or electrolytes remain unstable and obtain oncology-pharmacist approval before any recovery-phase formula. This is a precaution in an emergency involving renal and metabolic risk, not a herbal safety finding from source 4.[]

    When to reassess or seek care again

    See sources

    Acute or suspected TLS requires immediate referral, not a booked TCM review. After documented medical stabilisation and oncology clearance, review any supportive intervention within 7–14 days using fatigue and nausea scores (0–10), appetite, bowel pattern and functional activity. Laboratory follow-up remains oncology-led. Stop adjunctive care and refer immediately for reduced urine output, new systemic symptoms or abnormal renal/electrolyte results; seek medical review if recovery symptoms worsen or fail to improve over 2–4 weeks.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. PloS one · 2025
    2. Frontiers in pharmacology · 2026
    3. Frontiers in immunology · 2026
    4. International journal of emergency medicine · 2025
    5. Cochrane Database of Systematic Reviews · 2015

      Systematic review supporting PC6 stimulation for postoperative nausea and vomiting.

    6. JAMA Surgery · 2023

      Randomised trial including ST36 for postoperative gastrointestinal recovery.

    7. Medical Journal of Australia · 2017

      Australian emergency-department trial of acupuncture used alongside standard analgesic care.

    8. World Health Organization · 2008

      Standard point locations used for the adjunctive points listed.

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.